Kovack Advisors Inc. Boosts Holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Kovack Advisors Inc. grew its stake in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 8.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 133,792 shares of the company’s stock after acquiring an additional 9,917 shares during the quarter. Kovack Advisors Inc. owned about 0.16% of Stereotaxis worth $305,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of STXS. SG Americas Securities LLC lifted its holdings in shares of Stereotaxis by 39.2% during the 4th quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock valued at $60,000 after acquiring an additional 7,417 shares in the last quarter. Jane Street Group LLC lifted its stake in shares of Stereotaxis by 26.9% during the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after purchasing an additional 6,313 shares in the last quarter. Wealth Effects LLC lifted its stake in shares of Stereotaxis by 11.7% during the fourth quarter. Wealth Effects LLC now owns 86,060 shares of the company’s stock worth $196,000 after purchasing an additional 9,000 shares in the last quarter. Barclays PLC boosted its position in shares of Stereotaxis by 449.9% in the third quarter. Barclays PLC now owns 101,953 shares of the company’s stock worth $208,000 after buying an additional 83,412 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Stereotaxis by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock valued at $341,000 after buying an additional 15,491 shares in the last quarter. 45.35% of the stock is currently owned by hedge funds and other institutional investors.

Stereotaxis Stock Down 5.1 %

Shares of STXS stock opened at $2.06 on Friday. The firm has a market capitalization of $174.54 million, a PE ratio of -7.36 and a beta of 1.54. Stereotaxis, Inc. has a twelve month low of $1.66 and a twelve month high of $3.29.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.